Umair Seemab

Cited by

	All	Since 2020
Citations	180	161
h-index	5	5
i10-index	5	3

201220132014201520162017201820192020202120222023202420251 2 2 3 2 2 4 2 19 22 40 41 33 4

Public access

View all

3 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Ziaurrehman TanoliUniversity of HelsinkiVerified email at helsinki.fi
Andreas SchererCEO, SpheromicsVerified email at spheromics.com
Muhammad Sulaman NawazStatistics + BioinformaticsVerified email at decode.is
Sajid RashidNational Center for Bioinformatics, QAUVerified email at qau.edu.pk
Joseph NdikaHuman Microbiome Research Programme, University of HelsinkiVerified email at helsinki.fi
Vittorio FortinoAssociate Professor (University of Eastern Finland)Verified email at uef.fi
Piia KarisolaUniversity Researcher, docent, University of HelsinkiVerified email at helsinki.fi
Harri AleniusProfessor of Molecular Toxicology, Karolinska Institutet & Research Director, University of HelsinkiVerified email at ki.se
Prof. Mohammad A KamalKing Fahd Medical Research CenterVerified email at kau.edu.sa
Jehad AldahdoohResearcher in Computer ScienceVerified email at helsinki.fi
Zafar SaeedAssistant Professor, Università degli Studi di Bari - Dipartimento di InformaticaVerified email at uniba.it

Umair Seemab

University of Helsinki

Verified email at helsinki.fi

Bioinformatics Genome Analysis NGS RNA Bioinformatics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Exploration of databases and methods supporting drug repurposing: a comprehensive survey Z Tanoli, U Seemab, A Scherer, K Wennerberg, J Tang, M Vähä-Koskela Briefings in bioinformatics 22 (2), 1656-1678, 2021	111	2021
Silver, titanium dioxide, and zinc oxide nanoparticles trigger miRNA/isomiR expression changes in THP-1 cells that are proportional to their health hazard potential J Ndika, U Seemab, WL Poon, V Fortino, H El-Nezami, P Karisola, ... Nanotoxicology 13 (10), 1380-1395, 2019	25	2019
Prediction of structure of human WNT-CRD (FZD) complex for computational drug repurposing QU Ain, U Seemab, S Rashid, MS Nawaz, MA Kamal PLoS One 8 (1), e54630, 2013	14	2013
Integrative analyses of conserved WNT clusters and their co-operative behaviour in human breast cancer U Seemab, S Nawaz, S Rashid Bioinformation 7 (7), 339, 2011	13	2011
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments Z Tanoli, J Aldahdooh, F Alam, Y Wang, U Seemab, M Fratelli, P Pavlis, ... Briefings in Bioinformatics 23 (1), bbab350, 2022	12	2022
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models H Leinonen, J Zhang, LM Occelli, U Seemab, EH Choi, LF LP Marinho, ... Nature communications 15 (1), 5943, 2024	4	2024
Upregulation of Rod Ribbon Synapse Components Coincides with Well-preserved Scotopic Vision in the P23H Model of Retinitis Pigmentosa F Vinberg, F Abbas, EH Choi, M Tabaka, U Seemab, K Palczewski, ... Investigative Ophthalmology & Visual Science 63 (7), 2695-2695, 2022	1	2022
Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX S Korhonen, K Stenberg, U Seemab, P Bartos, K Mäkiniemi, J Kjems, ... Molecular Therapy Nucleic Acids 35 (4), 2024		2024
TrFAST: A Tool to Predict Signaling Pathway-specific Transcription Factor Binding Sites U Seemab, Q Ain, MS Nawaz, Z Saeed, S Rashid Genomics, Proteomics and Bioinformatics 10 (6), 354-359, 2012		2012

The system can't perform the operation now. Try again later.

Articles 1–9

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors